The study will evaluate the feasibility, acceptability, and effectiveness of AYUDA (Assisting Younger Adults with Diabetes), a 12-week culturally text message program for Latinx adults newly diagnosed with type 2 diabetes who are caregivers to a child under 18 years old within Kaiser Permanente Northern California.
After designing the AYUDA program with input from the people it is meant to help, we are conducting a randomized pilot study. This study will test the program with younger Latinx adults who have recently been diagnosed with type 2 diabetes and who are also caregivers for dependent children. AYUDA is a health system specifically designed for this group, focusing on their life stage as young adults and their cultural background. The study will evaluate how well AYUDA helps participants reach important early blood sugar control goals, which can lead to better health over time and reduce complications.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
21
Participants randomized to the intervention arm will be enrolled in the AYUDA program, where they will receive text messages twice a week over 12 weeks containing diabetes education and self-management resources, including links to resources available to all KPNC members.
Kaiser Permanente Northern California
Pleasanton, California, United States
Differences between study arms in HbA1c change 6-months following enrollment
Change in HbA1c will be assessed using HbA1c values obtained through routine care, with the most recent HbA1c preceding study enrollment and the HbA1c value closest to 6-months following enrollment used to assess HbA1c change.
Time frame: 6-months following enrollment
Healthcare contact
Differences in healthcare contact with members of the T2D diabetes care team, including care manager, PCPs, educators.
Time frame: 6-months following enrollment
Completion of recommended HbA1c monitoring
Completing HbA1c labs
Time frame: 6-months following enrollment
T2D-related medication initiation
Initiation of T2D-related medication
Time frame: 6-months following enrollment
T2D-related medication adherence
Adherence to T2D-related medication
Time frame: 6-months following enrollment
Use of remote glucose monitoring to measure glucose levels
Use of a remote glucose monitoring to measure glucose levels
Time frame: 6-months following enrollment
Participant-reported measures: Diabetes distress
Assessed at study enrollment and 6-months following enrollment
Time frame: Study enrollment and 6-months following enrollment
Participant-reported measures: Motivation and locus of control
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Assessed at study enrollment and 6-months following enrollment
Time frame: Study enrollment and 6-months following enrollment
Participant-reported measures: Care Experience
Assessed at study enrollment and 6-months following enrollment
Time frame: Study enrollment and 6-months following enrollment
Participant-reported measures: Children's Behaviors
Assessed at study enrollment and 6-months following enrollment
Time frame: Study enrollment and 6-months following enrollment